プロテイナーゼKの世界市場2020-2027:疾患種類別(神経、腫瘍、感染症)、形態別、地域別

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Model
1.3.1 Parent Market Study
1.3.1.1 Global Enzymes Market
1.3.1.2 Global IVD Market
1.3.1.3 Market Study, By Region
1.4 Objectives
1.4.1 OBJECTIVE 1:
1.4.2 OBJECTIVE 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Trends and Outlook
3.2 Market Segmentation and Scope
3.3 Market Lineage Outlook
3.3.1 Parent Market Analysis
3.3.1.1 IVD Market
3.3.1.2 Molecular Biology Enzymes And Kits Market
3.3.1.3 IVD Enzymes Market
3.3.1.4 Proteases Market
3.4 Pricing Analysis
3.4.1 Pricing and cost considerations
3.4.2 Pricing for Proteinase K: Bulk Order
3.4.3 Pricing for IVD-grade Proteinase K: General Orders
3.4.4 Pricing for Molecular-grade Proteinase K: General Orders
3.5 Impact of COVID-19
3.5.1 Total Number of COVID-19 Tests: Proteinase K, Global (Absolute Number)
3.6 Business Environment Analysis
3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6.2 Porter’s Five Forces Analysis
3.7 Penetration and Growth Prospect Mapping for Therapeutic Area, 2019 (USD Million)
Chapter 4 Market Dynamics
4.1 Market driver analysis
4.1.1 Broad applications of molecular diagnostic techniques and their associated enzymes for IVD
4.1.2 Rise in demand for point of care diagnostics coupled with the utility of proteinase K in POC diagnostic tests
4.1.3 Rising incidence of chronic disorders
4.2 Market Restraint Analysis
4.2.1 Reimbursement challenges associated with diagnostic tests
4.3 Market Opportunity Analysis
4.3.1 Applications in molecular biology and other fields
4.4 Market Challenge Analysis
4.4.1 Challenges associated with purification & recovery of enzymes
Chapter 5 Proteinase K Market: Therapeutic Area Estimates & Trend Analysis
5.1 Proteinase K Market: Therapeutic Area Movement Analysis
5.2 Infectious Diseases
5.2.1 Proteinase K market for infectious diseases, 2016 – 2027 (USD Million)
5.3 Diabetes
5.3.1 Proteinase K market for diabetes, 2016 – 2027 (USD Million)
5.4 Oncology
5.4.1 Proteinase K market for oncology, 2016 – 2027 (USD Million)
5.5 Cardiology
5.5.1 Proteinase K market for cardiology, 2016 – 2027 (USD Million)
5.6 Nephrology
5.6.1 Proteinase K market for nephrology, 2016 – 2027 (USD Million)
5.7 Autoimmune Diseases
5.7.1 Proteinase K market for autoimmune diseases, 2016 – 2027 (USD Million)
5.8 Neurology
5.8.1 Proteinase K market for neurology, 2016 – 2027 (USD Million)
5.9 Other therapeutic areas
5.9.1 Proteinase K market for other therapeutic areas, 2016 – 2027 (USD Million)
Chapter 6 Proteinase K Market: Form Estimates & Trend Analysis
6.1 Proteinase K Market: Form Movement Analysis
6.2 Powder
6.2.1 Powdered proteinase K market, 2016 – 2027 (USD Million)
6.3 Liquid
6.3.1 Liquid proteinase K market, 2016 – 2027 (USD Million)
Chapter 7 Proteinase K Market: Regional Estimates & Trend Analysis
7.1 Proteinase K Market: Regional Movement Analysis
7.2 North America
7.2.1 North America proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.2.2.2 U.S. proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.2.2.3 U.S. proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.2.3 Canada
7.2.3.1 Canada proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.2.3.2 Canada proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.2.3.3 Canada proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.3 Europe
7.3.1 Europe proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.2 Germany
7.3.2.1 Germany proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.2.2 Germany proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.3.2.3 Germany proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.3.3 France
7.3.3.1 France proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.3.2 France proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.3.3.3 France proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.3.4 U.K.
7.3.4.1 U.K. proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.4.2 U.K. proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.3.4.3 U.K. proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.3.5 Italy
7.3.5.1 Italy proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.5.2 Italy proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.3.5.3 Italy proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.3.6 Spain
7.3.6.1 Spain proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.3.6.2 Spain proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.3.6.3 Spain proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.4.2 Japan
7.4.2.1 Japan proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.4.2.2 Japan proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.4.2.3 Japan proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.4.3 China
7.4.3.1 China proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.4.3.2 China proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.4.3.3 China proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.4.4 India
7.4.4.1 India proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.4.4.2 India proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.4.4.3 India proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.5 Latin America
7.5.1 Latin America proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.5.2.2 Brazil proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.5.2.3 Brazil proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.5.3.2 Mexico proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.5.3.3 Mexico proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 MEA proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa proteinase K market estimates and forecast, 2016 – 2027 (USD Million)
7.6.2.2 South Africa proteinase K market estimates and forecast, by therapeutic area, 2016 – 2027 (USD Million)
7.6.2.3 South Africa proteinase K market estimates and forecast, by form, 2016 – 2027 (USD Million)
Chapter 8 COMPETITIVE LANDSCAPE
8.1 Strategy Framework
8.2 Market Participation Categorization
8.3 Company Profiles
8.3.1 Merck KGaA
8.3.1.1 Company overview
8.3.1.2 Sigma-Aldrich Co. LLC
8.3.1.2.1 Company overview
8.3.1.3 Financial performance
8.3.1.4 Product benchmarking
8.3.1.5 Strategic initiatives
8.3.2 Codexis
8.3.2.1 Company overview
8.3.2.2 Financial performance
8.3.2.3 Product benchmarking
8.3.2.4 Strategic initiatives
8.3.3 F. Hoffmann-La Roche Ltd.
8.3.3.1 Company overview
8.3.3.2 Financial performance
8.3.3.3 Product benchmarking
8.3.3.4 Strategic initiatives
8.3.4 Amano Enzymes
8.3.4.1 Company overview
8.3.4.2 Financial performance
8.3.4.3 Product benchmarking
8.3.4.4 Strategic initiatives
8.3.5 Advanced Enzymes Technologies Ltd.
8.3.5.1 Company overview
8.3.5.2 Financial performance
8.3.5.3 Product benchmarking
8.3.5.4 Strategic initiatives
8.3.6 Biocatalysts Ltd.
8.3.6.1 Company overview
8.3.6.2 Financial performance
8.3.6.3 Product benchmarking
8.3.6.4 Strategic initiatives
8.3.7 Amicogen
8.3.7.1 Company overview
8.3.7.2 Financial performance
8.3.7.3 Product benchmarking
8.3.7.4 Strategic initiatives
8.3.8 Dyadic International
8.3.8.1 Company overview
8.3.8.2 Financial performance
8.3.8.3 Product benchmarking
8.3.8.4 Strategic initiatives
8.3.9 BBI Solutions
8.3.9.1 Company overview
8.3.9.2 Financial performance
8.3.9.3 Product benchmarking
8.3.9.4 Strategic initiatives
8.3.10 Affymetrix
8.3.10.1 Company overview
8.3.10.2 Financial performance
8.3.10.3 Product benchmarking
8.3.10.4 Strategic initiatives
8.3.11 American Laboratories
8.3.11.1 Company overview
8.3.11.2 Financial performance
8.3.11.3 Product benchmarking
8.3.11.4 Strategic initiatives

グローバル市場調査会社